Literature DB >> 10556919

The role of protease-activated receptor-2 (PAR2) in the modulation of beating of the mouse isolated ureter: lack of involvement of mast cells or sensory nerves.

J D Moffatt1, T M Cocks.   

Abstract

1 The localization of protease-activated receptor-2 (PAR2) and the effects of PAR2 activators were investigated in the mouse isolated ureter in order to test the hypothesis that PAR2 activation may initiate neuropeptide release from sensory nerve fibres and hence contribute to inflammation. 2 PAR2 was localized by fluorescence immunohistochemistry to both the smooth muscle and epithelium of the ureter. Macrophage-like cells in the adventitia of the ureter were also PAR2-immunoreactive. PAR2-immunoreactivity was not observed in mast cells or nerve fibres. 3 In circular muscle preparations of the ureter in which continuous rhythmic beating was induced by KCl (20 mM) and the thromboxane A2 mimetic U46619 (0.3 microM), trypsin (0.3 U ml-1) reduced beat frequency to 84.6+/-2.0% of control rates. The PAR2-selective peptide agonist SLIGRL-NH2 concentration-dependently (0.1-3.0 microM) slowed beat frequency to a maximum of 72.7+/-2.0%. 4 Histamine (1-300 microM) was more efficacious than SLIGRL-NH2 in inhibiting ureter beat frequency in a concentration-dependent manner to a maximum (at 300 microM) of 7.9+/-2.5% of the control rate. 5 Pretreatment of preparations with capsaicin (10 microM for 30 min) markedly attenuated the inhibitory effect of histamine, but not that of SLIGRL-NH2, indicating a role for sensory nerves in the inhibitory effect of histamine only. 6 The inhibitory effect of SLIGRL-NH2 on ureter beat frequency was unaffected by the nitric oxide (NO) synthase inhibitor, L-NOARG (100 microM) or the cyclo-oxygenase inhibitor, indomethacin (3 microM). 7 In conclusion, PAR2 activation causes inhibition of beating in the mouse ureter that is not mediated by axon reflex release of inhibitory neuropeptides. This inhibitory effect of PAR2 appears to be mediated directly on smooth muscle cells, although the contribution of non-NO, non-prostanoid epithelium-derived factors cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556919      PMCID: PMC1571711          DOI: 10.1038/sj.bjp.0702871

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Proteinase-Activated Receptors: New Functions for Old Enzymes.

Authors:  Stephan K. Böhm; Karen McConalogue; Wuyi Kong; Nigel W. Bunnett
Journal:  News Physiol Sci       Date:  1998-10

Review 2.  The effects of tachykinins on inflammatory and immune cells.

Authors:  C A Maggi
Journal:  Regul Pept       Date:  1997-06-18

Review 3.  Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide.

Authors:  J M Lundberg
Journal:  Pharmacol Rev       Date:  1996-03       Impact factor: 25.468

4.  Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue.

Authors:  M Saifeddine; B al-Ani; C H Cheng; L Wang; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 5.  Tachykinins, sensory nerves, and asthma--an overview.

Authors:  J M Lundberg
Journal:  Can J Physiol Pharmacol       Date:  1995-07       Impact factor: 2.273

6.  Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor.

Authors:  M Saifeddine; S S Roy; B Al-Ani; C R Triggle; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1998-12       Impact factor: 8.739

7.  Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries.

Authors:  J D Moffatt; T M Cocks
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

8.  Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw.

Authors:  A Kawabata; R Kuroda; T Minami; K Kataoka; M Taneda
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

9.  A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.

Authors:  S He; M D Gaça; A F Walls
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

10.  Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport.

Authors:  N Vergnolle; W K Macnaughton; B Al-Ani; M Saifeddine; J L Wallace; M D Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  1 in total

1.  Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues.

Authors:  M R D'Andrea; C K Derian; R J Santulli; P Andrade-Gordon
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.